Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Systemic lupus erythematosis

NSAIDs are used as the first-line treatment of rheumatoid arthritis, osteoarthritis, systemic lupus erythematosis and other inflammatory diseases, and are thus amongst the most widely used dtugs in the developed world. This widespread use inevitably entailed a considerable associated morbidity, in particular a high incidence of gastric toxicity. In the USA alone, perforations, ulcers and bleeds lead to the hospitalisation of 100,000 patients per year, and about 15% of these die while under intensive care. [Pg.405]

The definition of an overlap syndrome dictates that the criteria for diagnosis of both disorders (in the present context, of PM/DM and of some other connective tissue disorder), are fulfilled. It is not unexpected that those syndromes which overlap with PM/DM are also either known autoimmune conditions or ones in which an autoimmune basis is strongly suspected. The association of these disorders with PM/DM syndromes may not materially alter the basic histopathological featmes expected in PM/DM but some differences may be identifiable. The disorders most frequently associated with an overlap syndrome are rheumatoid arthritis, systemic lupus erythematosis, scleroderma, and mixed connective tissue disease. [Pg.332]

Muller, S., Briand, J.P., Van, R.M.H. (1988). Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosis. Proc. Natl. Acad. Sci. USA 85,8176-8180. [Pg.458]

Twenty-five patients with systemic lupus erythematosis had high IgD antinuclear factor, and mean higher serum IgD concentrations were found in two groups of Vietnamese populations who live in an area endemic for malaria. [Pg.160]

Nanki T, Koike R, Miyasaka N. Subacute severe stea-tohepatitis during prednisolone therapy for systemic lupus erythematosis. Am J Gastroenterol 1999 94(11) 3379. [Pg.59]

This volume continues our objective of expanding the intellectual horizon of clinical chemistry. Included are chapters on Clinical Applications of Cytokine Assays Diagnosis and Treatment of Acute Pancreatitis Mitochondrial Mutations and Mitochondrial Diseases Pathobiochemistry of Nephrotic Syndrome Total Antioxidant Capacity Autoantibodies to dsDNA, Ro/SSA, and LaSSB in Systemic Lupus Erythematosis and Lymphoid Malignancies and Immunosuppressive Analysis. The meld of analytical, anatomical, subcellular, and molecular sciences represented by these subjects will continue to evolve and expand. Clinical chemistry is a vibrant and vital profession. Future volumes, their editors, and their contributors will undoubtedly be an important part of the practice and science of clinical chemistry. [Pg.379]

Linomide (A/-phenylmethyl-l,2-dihydro-4-hydroxyl-l-methyl-2-oxo-qui-noline-3-carboxamide, structure given in Table 1) has been proven to be an immunomodulator [32], In clinical trials, it has been shown to be a potential treatment for autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosis and multiple sclerosis [37-39]. It has also been reported to possess antiangiogenic activity [33,40]. [Pg.224]

D2. Davis, J. S., Godfrey, S. M., and Winfield, J. B., Direct evidence for circulating DNA/anti-DNA complexes in systemic lupus erythematosis. Arthritis Rheum. 21,17-22 (1978). [Pg.43]

Selectins include P-selectin (platelet selectin), E-selectin (endothelial cell selectin), and L-selectin (leukocyte selectin). P-selectin enables binding of platelets, polymorphonuclear leukocytes, and monocytes to activated endothelial cells and of leukocytes to activated platelets. P-selectin is expressed in the kidneys in systemic lupus erythematosis [266, 267]. The up-regulation of P-selectin expression in glomerui following binding of anti-GBM antibody may be an... [Pg.112]

Abbreviations NSAID = nonsteroidal anti-inflammatory drugs, PG = prostaglandin, RBF = renal blood flow, GFR = glomerular filtration rate,HTN = hypertension, DM = diabetes mellitus, = potassium, RAA = renin-angiotensin- aldosterone, CHF = congestive heart failure, AGE = angiotensin-converting enzyme, SLF = systemic lupus erythematosis. [Pg.424]

PMA phorbol myrastate acetate SLE systemic lupus erythematosis... [Pg.949]

Where percentages are noted, this is the approximate frequency among all patients experiencing CADRs. Systemic lupus erythematosis. [Pg.2436]

Prolonged TCE exposure has been associated with impairment of peripheral nervous system function, persistent neuritis and temporary loss of tactile sense and paralysis of the fingers after direct solvent contact. Chromosomal effects have been reported in those involved in the use of TCE for degreasing and symptoms of systemic lupus erythematosis have been reported after chronic TCE exposure. In addition, organic dementia has been noted after occupational exposure to TCE and there have been some reports of an association between exposure and scleroderma, an autoimmune disease. [Pg.2775]

Ishida, H., Kumagai, S., Umehara, H., Sano, H., Tagaya, Y., Yodoi, J., and Imura, H. Impaired expression of high affinity interleukin-2 receptor on activated lymphocytes from patients with systemic lupus erythematosis. J. Immunol. 139, 1070-1074 (1987). [Pg.69]

Hydralazine (Apresoline) Directly relaxes arterioles (not veins) independent of sympathetic interactions. Causes decrease in blood pressure leading to reflex tachycardia and increased cardiac output. Directly increases renal blood flow. Moderate hypertension. May be used in pregnant women who are hypertensive. Reflex tachycardia, palpitations, fluid retention, systemic lupus erythematosis-liKe syndrome. Chronic therapy may lead to peripheral neuritis (due to interference with vitamin B6 metabolism in neural tissue). [Pg.72]

Wide resistance of unknown mechanism. Dizziness, headache, i accommodation, bullseye retina, hemolysis in G6PD -deficient patients. PO, IM. Loading dose is 2X maintainance dose, half-life = 4 days. Dose must be increased in patients with rheumatoid arthritis or discoid systemic lupus erythematosis. [Pg.119]

Many reports have confirmed increased levels of serum/plasma MMPs (MMP-3, MMP-1, MMP-9) and TIMPs in patients with rheumatoid arthritis and systemic lupus erythematosis (SLE) and to a lesser degree gout, osteoarthritis, and scleroderma (Z9). [Pg.59]


See other pages where Systemic lupus erythematosis is mentioned: [Pg.37]    [Pg.102]    [Pg.230]    [Pg.134]    [Pg.188]    [Pg.69]    [Pg.296]    [Pg.1865]    [Pg.341]    [Pg.799]    [Pg.239]    [Pg.179]    [Pg.219]    [Pg.293]    [Pg.394]    [Pg.293]    [Pg.394]    [Pg.833]    [Pg.2549]    [Pg.36]    [Pg.684]    [Pg.58]    [Pg.528]    [Pg.952]    [Pg.931]    [Pg.680]    [Pg.230]   
See also in sourсe #XX -- [ Pg.102 ]

See also in sourсe #XX -- [ Pg.59 ]

See also in sourсe #XX -- [ Pg.1619 ]

See also in sourсe #XX -- [ Pg.675 ]




SEARCH



Systemic lupus

© 2024 chempedia.info